Byron Cryer
Impact in
- Gastroenterology top 0.2%
- Gastroesophageal reflux and treatments
- Gastrointestinal motility and disorders
- Gastrointestinal Bleeding Diagnosis and Treatment
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
Papers in
-
- Gastroesophageal reflux and treatments 23
- Gastrointestinal motility and disorders 11
- Pharmacology 58
- Inflammatory mediators and NSAID effects 58
- Drug-Induced Adverse Reactions 15
- Co-authors
- Mark FeldmanLoren LaineChristopher P. CannonStuart J. SpechlerDeepak L. BhattC. Mel WilcoxJay L. GoldsteinMark A. Goldsmith
- Journals
- Gastroenterology (25 papers)The American Journal of Gastroenterology (12 papers)Digestive Diseases and Sciences (7 papers)Clinical Gastroenterology and Hepatology (6 papers)Alimentary Pharmacology & Therapeutics (5 papers)
- Partner nations
- United StatesSpainJapan
In The Last Decade
Byron Cryer
128 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Gastroenterology 1.2k
- Pharmacology 1.6k
- Cardiology and Cardiovascular Medicine 1.5k
- Internal Medicine 200
- Surgery 2.1k
Countries citing papers authored by Byron Cryer
This map shows the geographic impact of Byron Cryer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron Cryer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron Cryer more than expected).
Fields of papers citing papers by Byron Cryer
This network shows the impact of papers produced by Byron Cryer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron Cryer. The network helps show where Byron Cryer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Byron Cryer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2017 | 106 | |
| 3 | 2017 | 33 | |
| 4 | 2016 | 7 | |
| 5 | 2016 | 1 | |
| 6 | 2016 | 33 | |
| 7 | 2013 | 3 | |
| 8 | 2013 | 39 | |
| 9 | 2011 | 21 | |
| 10 | 2011 | 13 | |
| 11 | 2010 | 60 | |
| 12 | Clopidogrel with or without Omeprazole in Coronary Artery Disease Hit paper breakdown → | 2010 | 794 |
| 13 | 2009 | 15 | |
| 14 | 2006 | 66 | |
| 15 | 2005 | 13 | |
| 16 | 2005 | 1 | |
| 17 | 2005 | 17 | |
| 18 | 2004 | 57 | |
| 19 | 2003 | 25 | |
| 20 | 2002 | 102 |
About Byron Cryer
Byron Cryer is a scholar working on Gastroenterology, Pharmacology, Cardiology and Cardiovascular Medicine, Surgery and Biochemistry, having authored 132 papers that have together received 5.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (58 papers), Helicobacter pylori-related gastroenterology studies (35 papers), Antiplatelet Therapy and Cardiovascular Diseases (34 papers), Gastroesophageal reflux and treatments (23 papers), Drug-Induced Adverse Reactions (15 papers), Gastrointestinal motility and disorders (11 papers), Eosinophilic Esophagitis (9 papers) and Gastric Cancer Management and Outcomes (9 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Pharmacology (1.6k citations), Cardiology and Cardiovascular Medicine (1.5k citations), Internal Medicine (200 citations) and Surgery (2.1k citations). Byron Cryer has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Mark Feldman, Loren Laine, Christopher P. Cannon, Stuart J. Spechler, Deepak L. Bhatt, C. Mel Wilcox, Jay L. Goldstein, Mark A. Goldsmith, Pablo Lapuerta and Thomas J. Schnitzer. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Digestive Diseases and Sciences, Clinical Gastroenterology and Hepatology and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.